Risk of avascular necrosis following short term megadose methylprednisolone treatment

Spinal Cord

Volumn 36, Issue 9, 1998, Pages 633-636

  Wing, P C ^a   Nance, P ^b   Connell, D G ^a   Gagnon, F ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Adverse effects; Methylprednisolone; Osteonecrosis; Spinal cord injury

Indexed keywords

METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMUR HEAD NECROSIS; HUMAN; HUMERUS HEAD; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPINAL CORD INJURY; STATISTICS;

EID: 0031719738     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100647     Document Type: Article

References (19)

1. Collins WF. A review and update of experimental and clinical studies of spinal cord injury. Paraplegia 1983; 21: 204-219.
2. Braugler JM, Hall ED. Current application of 'high-dose' steroid therapy for CNS injury. J Neurosurg 1985; 62: 806-810.
3. Hall ED, Braughler JM. Non-surgical management of spinal cord injuries: a review of studies with the glucocorticoid steroid methylprednisolone. Acta Anaesth Belgica 1987; 38: 405-409.
4. Bracken MB et al. Methylprednisolone and neurological function 1 year after spinal cord injury. J Neurosurg 1985; 63: 704-713.
5. Bracken MB et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Results of the second National Acute Spinal Cord Injury Study. New Engl J Med 1990; 322: 1405-1411.
6. Leake GC, Pascale VJ, Alfano SL, Bracken MB. Methylprednisolone for acute spinal cord injury [letter]. Am J Hosp Pharm 1990 Sep; 47: 1977-1978.
7. Saisu T et al. High incidence of osteonecrosis of femoral head in patients receiving more than 2 g of intravenous methylprednisolone after renal transplantation. Transplantation Proceedings 1996; 28: 1559-1560.
8. Marsh JC et al. Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone. Br J Haematol 1993; 84: 731-735.
9. Massardo L et al. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus. Lupus 1992; 1: 401-405.
10. Migliaresi S et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37-41.
11. Osebold WR, Kody MH. Bilateral humeral head osteonecrosis following spinal cord injury: a case report illustrating the importance of adhering to the recommendations of the Second National Acute Spinal Cord Injury Study. Iowa Orthop J 1994; 14: 120-124.
12. O'Brien TO, Mack GO. Multifocal osteonecrosis after short-term high-dose corticosteroid therapy. A case report. Cain Orthop 1992; 279: 176-179.
13. Anderson JM, Orth M, Helm MB. Multiple joint osteonecrosis following short-term steroid therapy: a case report. J Bone Joint Surg 1982; 64A: 139.
14. Avital F, Alon M, Weiss S, Zer-Aviv F. Avascular necrosis of bone following short-term dexamethasone therapy for brain edema: a case report. J Neurosurg 1984; 61: 983.
15. Samhrook PN, Hassall JE, York JR. Osteonecrosis after high dosage, short term corticosteroid therapy. J Rheumatol 1984; 11: 514.
16. Taylor LF. Multifocal avascular necrosis after short-term high-dose steroid therapy: a report of three cases. J Bone Joint Surg 1984; 66B: 431.
17. Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1987; 18: 902.
18. Hilton G, Frei J. High-dose methylprednisolone in the treatment of spinal cord injuries. Heart Lung 1991; 20: 675-680.
19. Bracken MB et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. JAMA 1997; 277: 1597-1604.